Cargando…

Metabotropic Glutamate Receptor 5 and 8 Modulate the Ameliorative Effect of Ultramicronized Palmitoylethanolamide on Cognitive Decline Associated with Neuropathic Pain

This study investigated whether metabotropic glutamate receptor (mGluR) 5 and 8 are involved in the effect of ultramicronizedpalmitoylethanolamide (um-PEA) on the cognitive behavior and long term potentiation (LTP) at entorhinal cortex (LEC)-dentate gyrus (DG) pathway in mice rendered neuropathic by...

Descripción completa

Detalles Bibliográficos
Autores principales:	Boccella, Serena, Marabese, Ida, Iannotta, Monica, Belardo, Carmela, Neugebauer, Volker, Mazzitelli, Mariacristina, Pieretti, Gorizio, Maione, Sabatino, Palazzo, Enza
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6480075/ https://www.ncbi.nlm.nih.gov/pubmed/30970677 http://dx.doi.org/10.3390/ijms20071757

Ejemplares similares

Group II Metabotropic Glutamate Receptors: Role in Pain Mechanisms and Pain Modulation
por: Mazzitelli, Mariacristina, et al.
Publicado: (2018)

The Modulation of Pain by Metabotropic Glutamate Receptors 7 and 8 in the Dorsal Striatum
por: Boccella, Serena, et al.
Publicado: (2020)

Metabotropic Glutamate Receptor 7: From Synaptic Function to Therapeutic Implications
por: Palazzo, Enza, et al.
Publicado: (2016)

Methods for Evaluating Sensory, Affective and Cognitive Disorders in Neuropathic Rodents
por: Palazzo, Enza, et al.
Publicado: (2021)

Editorial: Metabotropic Glutamate Receptors and Neurological/Psychiatric Disorders
por: Palazzo, Enza, et al.
Publicado: (2019)

Behavioral, Biochemical and Electrophysiological Changes in Spared Nerve Injury Model of Neuropathic Pain
por: Guida, Francesca, et al.
Publicado: (2020)

The Cold Case of Metabotropic Glutamate Receptor 6: Unjust Detention in the Retina?
por: Palazzo, E., et al.
Publicado: (2020)

Oral Cannabidiol Prevents Allodynia and Neurological Dysfunctions in a Mouse Model of Mild Traumatic Brain Injury
por: Belardo, Carmela, et al.
Publicado: (2019)

Effects of a metabotropic glutamate receptor subtype 7 negative allosteric modulator in the periaqueductal grey on pain responses and rostral ventromedial medulla cell activity in rat
por: Palazzo, Enza, et al.
Publicado: (2013)

Palmitoylethanolamide Reduces Neuropsychiatric Behaviors by Restoring Cortical Electrophysiological Activity in a Mouse Model of Mild Traumatic Brain Injury
por: Guida, Francesca, et al.
Publicado: (2017)

Short-Term Efficacy of Ultramicronized Palmitoylethanolamide in Peripheral Neuropathic Pain
por: Cocito, Dario, et al.
Publicado: (2014)

Comment on “Short-Term Efficacy of Ultramicronized Palmitoylethanolamide in Peripheral Neuropathic Pain”
por: Kriek, R.
Publicado: (2014)

Effects of Palmitoylethanolamide (PEA) on Nociceptive, Musculoskeletal and Neuropathic Pain: Systematic Review and Meta-Analysis of Clinical Evidence
por: Scuteri, Damiana, et al.
Publicado: (2022)

Vitamin D Deficiency Induces Chronic Pain and Microglial Phenotypic Changes in Mice
por: Alessio, Nicola, et al.
Publicado: (2021)

2-Pentadecyl-2-oxazoline ameliorates memory impairment and depression-like behaviour in neuropathic mice: possible role of adrenergic alpha2- and H3 histamine autoreceptors
por: Boccella, Serena, et al.
Publicado: (2021)

Correction to: 2-Pentadecyl-2-oxazoline ameliorates memory impairment and depression-like behaviour in neuropathic mice: possible role of adrenergic alpha2- and H3 histamine autoreceptors
por: Boccella, Serena, et al.
Publicado: (2021)

Recent Advances in the Modulation of Pain by the Metabotropic Glutamate Receptors
por: Mazzitelli, Mariacristina, et al.
Publicado: (2022)

EP1 receptor within the ventrolateral periaqueductal grey controls thermonociception and rostral ventromedial medulla cell activity in healthy and neuropathic rat
por: Palazzo, Enza, et al.
Publicado: (2011)

Palmitoylethanolamide reduces pain-related behaviors and restores glutamatergic synapses homeostasis in the medial prefrontal cortex of neuropathic mice
por: Guida, F., et al.
Publicado: (2015)

The Beneficial Effects of Ultramicronized Palmitoylethanolamide in the Management of Neuropathic Pain and Associated Mood Disorders Induced by Paclitaxel in Mice
por: Cristiano, Claudia, et al.
Publicado: (2022)

Long-term neuropathic pain behaviors correlate with synaptic plasticity and limbic circuit alteration: a comparative observational study in mice
por: Guida, Francesca, et al.
Publicado: (2022)

Co-ultramicronized Palmitoylethanolamide/Luteolin Promotes the Maturation of Oligodendrocyte Precursor Cells
por: Barbierato, Massimo, et al.
Publicado: (2015)

Ultramicronized Palmitoylethanolamide in the Management of Sepsis-Induced Coagulopathy and Disseminated Intravascular Coagulation
por: D’Amico, Ramona, et al.
Publicado: (2021)

The blockade of the transient receptor potential vanilloid type 1 and fatty acid amide hydrolase decreases symptoms and central sequelae in the medial prefrontal cortex of neuropathic rats
por: de Novellis, Vito, et al.
Publicado: (2011)

Co-ultramicronized Palmitoylethanolamide/Luteolin in the Treatment of Cerebral Ischemia: from Rodent to Man
por: Caltagirone, Carlo, et al.
Publicado: (2015)

Oral Ultramicronized Palmitoylethanolamide: Plasma and Tissue Levels and Spinal Anti-hyperalgesic Effect
por: Petrosino, Stefania, et al.
Publicado: (2018)

Add-on administration of ultramicronized palmitoylethanolamide in the treatment of new-onset burning mouth syndrome
por: Chirchiglia, Domenico, et al.
Publicado: (2019)

Micronized / ultramicronized palmitoylethanolamide (PEA) as natural neuroprotector against COVID-19 inflammation
por: Roncati, Luca, et al.
Publicado: (2021)

Micronized/ultramicronized palmitoylethanolamide displays superior oral efficacy compared to nonmicronized palmitoylethanolamide in a rat model of inflammatory pain
por: Impellizzeri, Daniela, et al.
Publicado: (2014)

Erratum to: Micronized/ultramicronized palmitoylethanolamide displays superior oral efficacy compared to nonmicronized palmitoylethanolamide in a rat model of inflammatory pain
por: Impellizzeri, Daniela, et al.
Publicado: (2016)

Palmitoylethanolamide reduces granuloma-induced hyperalgesia by modulation of mast cell activation in rats
por: De Filippis, Daniele, et al.
Publicado: (2011)

Co-Ultramicronized Palmitoylethanolamide/Luteolin Promotes Neuronal Regeneration after Spinal Cord Injury
por: Crupi, Rosalia, et al.
Publicado: (2016)

Combination of Rehabilitative Therapy with Ultramicronized Palmitoylethanolamide for Chronic Low Back Pain: An Observational Study
por: Scaturro, Dalila, et al.
Publicado: (2019)

Ultramicronized Palmitoylethanolamide (um-PEA): A New Possible Adjuvant Treatment in COVID-19 patients
por: Noce, Annalisa, et al.
Publicado: (2021)

Effect of ultramicronized-palmitoylethanolamide and co-micronized palmitoylethanolamide/polydatin on chronic pelvic pain and quality of life in endometriosis patients: An open-label pilot study
por: Stochino Loi, Emanuela, et al.
Publicado: (2019)

A new co-ultramicronized composite including palmitoylethanolamide and luteolin to prevent neuroinflammation in spinal cord injury
por: Paterniti, Irene, et al.
Publicado: (2013)

Looking for a Treatment for the Early Stage of Alzheimer’s Disease: Preclinical Evidence with Co-Ultramicronized Palmitoylethanolamide and Luteolin
por: Facchinetti, Roberta, et al.
Publicado: (2020)

Effects of Ultramicronized Palmitoylethanolamide (um-PEA) in COVID-19 Early Stages: A Case–Control Study
por: Albanese, Maria, et al.
Publicado: (2022)

Erratum to: A new co-ultramicronized composite including palmitoylethanolamide and luteolin to prevent neuroinflammation in spinal cord injury
por: Paterniti, Irene, et al.
Publicado: (2016)

Oral Supplementation with Ultramicronized Palmitoylethanolamide for Joint Disease and Lameness Management in Four Jumping Horses: A Case Report
por: Gugliandolo, Enrico, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_he9hrrf4kptdv00p4tcrkshkh4